Modified COVID Vaccines: FDA Shifts To Superiority Standard For Immune Response To Variants

 
• By Sue Sutter
Pulling the trigger
The immunogenicity comparisons FDA wants to see are "really important data to decide if and when to pull the trigger on a variant vaccine," Georgetown's Jesse Goodman says. • Source: Alamy

More from Vaccines

More from Pink Sheet